Evidence map›Paper›PMID 23096997›Full record

ArticleMammalian genome : official journal of the International Mammalian Genome Society2013

Creation and characterization of BAC-transgenic mice with physiological overexpression of epitope-tagged RCAN1 (DSCR1).

Luzhou Xing, Martha Salas, Hong Zhang, Julia Gittler, Thomas Ludwig, Chyuan-Sheng Lin, Vundavalli V Murty, Wayne Silverman, Ottavio Arancio, Benjamin Tycko

Open access · greenAbstract read
In one paragraph

Article in Mammalian genome : official journal of the International Mammalian Genome Society, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Luzhou XingInstitute for Cancer Genetics, Columbia University Medical Center, Herbert Irving Cancer Research Building, New York, NY 10032, USA.
Martha Salas
Hong Zhang
Julia Gittler
Thomas Ludwig
Chyuan-Sheng Lin
Vundavalli V Murty
Wayne Silverman
Ottavio Arancio
Benjamin Tycko
Columbia University Irving Medical Center · USCancer Genetics (United States) · USKennedy Krieger Institute · US

Funding

Vulnerability to Alzheimers Disease in Down SyndromeP01HD035897 · NICHD · NEW YORK STATE OFFICE OF MENTAL HEALTH · PI KRINSKY-MCHALE, SHARON J · 1998 to 2014
$19.2M
Endogenous amyloid-beta in synaptic function and memoryR01AG034248 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ARANCIO, OTTAVIO · 2010 to 2014
$1.7M
NIA NIH HHS R01 AG034248NIA NIH HHS R01-AG034248NICHD NIH HHS P01 HD035897NICHD NIH HHS P01-HD035897
6 · The paper itself

Abstract

The chromosome 21 gene RCAN1, encoding a modulator of the calcineurin (CaN) phosphatase, is a candidate gene for contributing to cognitive disability in people with Down syndrome (DS; trisomy 21). To develop a physiologically relevant model for studying the biochemistry of RCAN1 and its contribution to DS, we generated bacterial artificial chromosome-transgenic (BAC-Tg) mouse lines containing the human RCAN1 gene with a C-terminal HA-FLAG epitope tag incorporated by recombineering. The BAC-Tg was expressed at levels only moderately higher than the native Rcan1 gene: approximately 1.5-fold in RCAN1 (BAC-Tg1) and twofold in RCAN1 (BAC-Tg2). Affinity purification of the RCAN1 protein complex from brains of these mice revealed a core complex of RCAN1 with CaN, glycogen synthase kinase 3-beta (Gsk3b), and calmodulin, with substoichiometric components, including LOC73419. The BAC-Tg mice are fully viable, but long-term synaptic potentiation is impaired in proportion to BAC-Tg dosage in hippocampal brain slices from these mice. RCAN1 can act as a tumor suppressor in some systems, but we found that the RCAN1 BAC-Tg did not reduce mammary cancer growth when present at a low copy number in Tp53;WAP-Cre mice. This work establishes a useful mouse model for investigating the biochemistry and dose-dependent functions of the RCAN1 protein in vivo.

Indexed as

Gene Expression RegulationMice, TransgenicAnimalsBrainCalcineurinCells, CulturedChromosomesChromosomes, Artificial, BacterialDisease Models, AnimalDNA-Binding ProteinsDown SyndromeFemaleGene DosageGenetic LociGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaCalcineurinDNA-Binding ProteinsGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaGSK3B protein, humanGsk3b protein, mouseIntracellular Signaling Peptides and ProteinsMuscle ProteinsRCAN1 protein, human

Identifiers

PMID23096997
PMCPMC3562396
OpenAlexW2069240256

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.